Prostate News Archive
23-May-2009
Results of phase I trial of novel herbal therapy for men at high risk of prostate cancer (EurekAlert!)
( Columbia University Medical Center ) Results of a phase I clinical trial of a novel herb-based therapeutic called Zyflamend have demonstrated that the therapy is associated with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer. Herbal drug lowers prostate cancer risk (The Times of India)
WASHINGTON: A novel herb-based therapeutic called Zyflamend has been found to be linked with minimal toxicity and no serious adverse events in men at high-risk for developing prostate cancer in its phase I clinical trial. Quick Test For Prostate Cancer (Science Daily)
A new three-minute test could help in diagnosing prostate cancer, the most common cancer in men in the UK, according to scientists. Dr. David B. Samadi Introduces New Prostate Cancer Care Center For Robotic Surgery Patients At Mount Sinai Medical ... (Medical News Today)
The Mount Sinai Medical Center has a new resource center for prostate cancer treatment. Led by David B. Samadi, M.D.
Back to Prostate News Archive
